• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清型 O9 疫苗的效力。

Efficacy of a serogroup O9 vaccine.

机构信息

Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, USA.

Emory+Children's Center for Cystic Fibrosis and Airway Disease Research, Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Infect Immun. 2023 Dec 12;91(12):e0024723. doi: 10.1128/iai.00247-23. Epub 2023 Nov 22.

DOI:10.1128/iai.00247-23
PMID:37991349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10715167/
Abstract

There are currently no approved vaccines against the opportunistic pathogen . Among vaccine targets, the lipopolysaccharide (LPS) O antigen of is the most immunodominant protective candidate. There are 20 different O antigens composed of different repeat sugar structures conferring serogroup specificity, and 10 are found most frequently in infection. Thus, one approach to combat infection by could be to generate immunity with a vaccine cocktail that includes all these serogroups. Serogroup O9 is 1 of the 10 serogroups commonly found in infection, but it has never been developed into a vaccine, due in part to the acid-labile nature of the O9 polysaccharide. Our laboratory has previously shown that intranasal administration of an attenuated strain expressing the serogroup O11 LPS O antigen was effective in clearing bacteria and preventing mortality in mice following intranasal challenge with serogroup O11 . Consequently, we set out to develop a serogroup O9 vaccine using a similar approach. Here, we show that expressing serogroup O9 triggered an antibody-mediated immune response following intranasal administration to mice and that it conferred protection from serogroup O9 in a murine model of acute pneumonia.

摘要

目前尚无针对机会性病原体的批准疫苗。在疫苗靶标中,的脂多糖(LPS)O 抗原是最具免疫优势的保护性候选物。有 20 种不同的 O 抗原由赋予血清组特异性的不同重复糖结构组成,其中 10 种在感染中最常发现。因此,对抗感染的一种方法可能是使用包含所有这些血清组的疫苗鸡尾酒来产生免疫力。血清组 O9 是感染中最常发现的 10 个血清组之一,但由于 O9 多糖的酸不稳定性质,从未将其开发成疫苗。我们的实验室之前曾表明,鼻腔内给予表达血清组 O11 LPS O 抗原的减毒 株可有效清除细菌,并在鼻腔内用血清组 O11 攻击后预防小鼠的死亡率。因此,我们着手使用类似的方法开发血清组 O9 疫苗。在这里,我们表明,鼻腔内给予表达血清组 O9 的可引发抗体介导的免疫反应,并且在急性肺炎的小鼠模型中可提供针对血清组 O9 的保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/8e981d3fc81e/iai.00247-23.f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/10437735bdfb/iai.00247-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/a29befd88b28/iai.00247-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/25dfe38273bf/iai.00247-23.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/dcbd38655996/iai.00247-23.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/5534fd343ee3/iai.00247-23.f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/8e981d3fc81e/iai.00247-23.f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/10437735bdfb/iai.00247-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/a29befd88b28/iai.00247-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/25dfe38273bf/iai.00247-23.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/dcbd38655996/iai.00247-23.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/5534fd343ee3/iai.00247-23.f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/10715167/8e981d3fc81e/iai.00247-23.f006.jpg

相似文献

1
Efficacy of a serogroup O9 vaccine.血清型 O9 疫苗的效力。
Infect Immun. 2023 Dec 12;91(12):e0024723. doi: 10.1128/iai.00247-23. Epub 2023 Nov 22.
2
Efficacy of a Serogroup O9 Vaccine.O9血清群疫苗的效力
bioRxiv. 2023 Jul 13:2023.07.13.548830. doi: 10.1101/2023.07.13.548830.
3
Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.黏膜接种多价、减毒活疫苗可诱导多因素抗铜绿假单胞菌急性肺部感染的免疫。
Infect Immun. 2011 Mar;79(3):1289-99. doi: 10.1128/IAI.01139-10. Epub 2010 Dec 13.
4
Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.鼠胃肠道中的铜绿假单胞菌清除是由O抗原特异性循环抗体有效介导的。
Infect Immun. 1995 Aug;63(8):2818-25. doi: 10.1128/iai.63.8.2818-2825.1995.
5
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.用减毒活aroA缺失突变体经鼻腔免疫小鼠后对致死性铜绿假单胞菌肺炎的保护作用。
Infect Immun. 2003 Mar;71(3):1453-61. doi: 10.1128/IAI.71.3.1453-1461.2003.
6
Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains.小鼠对从铜绿假单胞菌O2血清型菌株中分离出的变异高分子量O多糖的复杂血清学和免疫反应。
Infect Immun. 1998 Aug;66(8):3719-26. doi: 10.1128/IAI.66.8.3719-3726.1998.
7
Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.用表达铜绿假单胞菌O抗原的鼠伤寒沙门氏菌对BALB/c小鼠进行口服疫苗接种,可提高急性致死性肺炎模型中的存活率。
Infect Immun. 2004 Dec;72(12):7012-21. doi: 10.1128/IAI.72.12.7012-7021.2004.
8
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.白细胞介素-17是疫苗诱导的针对铜绿假单胞菌脂多糖异源菌株肺部感染的保护性反应的关键组成部分。
J Immunol. 2008 Oct 1;181(7):4965-75. doi: 10.4049/jimmunol.181.7.4965.
9
Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.铜绿假单胞菌aroA基因缺失减毒活突变株的构建与鉴定作为鼻内疫苗候选物
Infect Immun. 2002 Mar;70(3):1507-17. doi: 10.1128/IAI.70.3.1507-1517.2002.
10
Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.利用肠炎沙门氏菌鼠伤寒血清型wecA突变株进行异源铜绿假单胞菌O抗原传递。
Int J Med Microbiol. 2016 Nov;306(7):529-540. doi: 10.1016/j.ijmm.2016.06.005. Epub 2016 Jun 28.

引用本文的文献

1
Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce burden in mice.源自囊性纤维化患者B细胞的单克隆抗体可减轻小鼠的负担。
Elife. 2025 Apr 24;13:RP98851. doi: 10.7554/eLife.98851.
2
Vaccine Development: Lessons, Challenges, and Future Innovations.疫苗研发:经验教训、挑战与未来创新
Int J Mol Sci. 2025 Feb 25;26(5):2012. doi: 10.3390/ijms26052012.
3
Mucin adhesion of serial cystic fibrosis airways isolates.连续囊性纤维化气道分离株的粘蛋白黏附。

本文引用的文献

1
Salmonella delivers H9N2 influenza virus antigens via a prokaryotic and eukaryotic dual-expression vector and elicits bivalent protection against avian influenza and fowl typhoid.沙门氏菌通过原核和真核双表达载体递送H9N2流感病毒抗原,并引发针对禽流感和禽伤寒的双价保护。
Dev Comp Immunol. 2023 Dec;149:105058. doi: 10.1016/j.dci.2023.105058. Epub 2023 Sep 14.
2
A Fatal Case of Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review.一例免疫功能正常患者的社区获得性肺炎致死病例:临床与分子特征及文献综述
Microorganisms. 2023 Apr 24;11(5):1112. doi: 10.3390/microorganisms11051112.
3
Front Cell Infect Microbiol. 2024 Aug 22;14:1448104. doi: 10.3389/fcimb.2024.1448104. eCollection 2024.
4
Mechanisms of antibody-dependent enhancement of infectious disease.抗体依赖性传染病增强机制。
Nat Rev Immunol. 2025 Jan;25(1):6-21. doi: 10.1038/s41577-024-01067-9. Epub 2024 Aug 9.
5
Optimization of the Synthesis and Conjugation of the Methyl Rhamnan Tip of A-Band Polysaccharide and Immunogenicity Evaluation for the Continued Development of a Potential Glycoconjugate Vaccine.优化 A 带多糖甲基鼠李糖末端的合成和缀合及其免疫原性评价,为潜在糖缀合物疫苗的持续开发提供支持。
ACS Infect Dis. 2024 Apr 12;10(4):1361-1369. doi: 10.1021/acsinfecdis.4c00049. Epub 2024 Mar 6.
Anti- Vaccines and Therapies: An Assessment of Clinical Trials.
抗疫苗与疗法:临床试验评估
Microorganisms. 2023 Mar 31;11(4):916. doi: 10.3390/microorganisms11040916.
4
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters.活疫苗 sCPD9 可诱导仓鼠对 SARS-CoV-2 变体产生更强的黏膜和系统免疫。
Nat Microbiol. 2023 May;8(5):860-874. doi: 10.1038/s41564-023-01352-8. Epub 2023 Apr 3.
5
Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses.经口接种重组轮状病毒诱导婴儿小鼠产生诺如病毒黏膜和系统中和抗体。
Proc Natl Acad Sci U S A. 2023 Feb 28;120(9):e2214421120. doi: 10.1073/pnas.2214421120. Epub 2023 Feb 23.
6
A genetically engineered parasite vaccine provides protection from controlled human malaria infection.一种基因工程寄生虫疫苗为人体疟疾感染提供了保护。
Sci Transl Med. 2022 Aug 24;14(659):eabn9709. doi: 10.1126/scitranslmed.abn9709.
7
: Recent Advances in Vaccine Development.疫苗研发的最新进展
Vaccines (Basel). 2022 Jul 8;10(7):1100. doi: 10.3390/vaccines10071100.
8
Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection.多国分离侵袭性铜绿假单胞菌血清型分布及耐药性分析。
BMC Microbiol. 2022 Jan 6;22(1):13. doi: 10.1186/s12866-021-02427-4.
9
Immunization and Immunotherapy Approaches against and Complex Infections.针对寄生虫和复杂感染的免疫接种及免疫治疗方法。
Vaccines (Basel). 2021 Jun 18;9(6):670. doi: 10.3390/vaccines9060670.
10
Synthesis and delivery of capsular polysaccharides by recombinant attenuated vaccines.通过重组减毒疫苗合成和传递荚膜多糖。
Proc Natl Acad Sci U S A. 2021 Jan 12;118(2). doi: 10.1073/pnas.2013350118.